Company: BGLC
Filing Date: 2025-02-27
Form Type: DEF 14A
Source: 0001477932-25-001335
Chunk: 31

Company: BioNexus Gene Lab Corp
Filing Date: 2025-02-27
Form: DEF 14A
Chunk 31
---
 below. Notwithstanding the immediately preceding sentence, no fractional shares will be issued in connection with the combination effected by the preceding sentence. Any fractional share of a holder resulting from the filing of this Articles of Amendment shall be repurchased by the Company at “fair value” and canceled, rather than being converted into whole shares. This filing of the Articles of Amendment shall also apply to any outstanding securities or rights convertible into, or exchangeable or exercisable for, Common Stock of the Corporation and all references to such Common Stock in agreements, arrangements, documents and plans relating thereto or any option or right to purchase or acquire shares of Common Stock shall be deemed to be references to the Common Stock or options or rights to purchase or acquire shares of Common Stock, as the case may be, after the filing of this Articles of Amendment.”

IN WITNESS WHEREOF, the Corporation has caused to be signed by its duly authorized officer as of this _____ day of __________, 2025.

| Su-Leng Tan Lee  Chief Executive Officer |

| 21 |

| Control Number: | Number of Shares: | Registered Shareholder: |

<div align='center'>BIONEXUS GENE LAB CORP.

Unit A-28-7, Tower A, Menara UOA Bangsar,

No.5 Jln Bangsar Utama 1

59000 Kuala Lumpur

PROXY

Solicited on Behalf of the Board of Directors for a Special Meeting of Shareholders - March 19, 2025</div>

The undersigned hereby appoints Su-Leng Tan Lee, as proxy with full power of substitution, to represent and vote as set forth herein all the common shares of BioNexus Gene Lab Corp. which the undersigned is entitled to vote at the Special Meeting of Shareholders and any adjournments or postponements thereof, as designated below. If no designation is made, the proxy, when properly executed, will be voted “FOR” in Items 1, and 2.

Item 1 Approval of an amendment to our Amended and Restated Certificate of Incorporation to effect a reverse stock split of our outstanding shares of common stock, no par value, at a ratio, ranging from one-for-five (1:5) to one-for-ten (1:10), with the exact ratio to be set within that range at the discretion of our Board of Directors without further approval or authorization of our stockholders (the “Reverse Stock Split Proposal”); and

| ☐ | For | ☐ | Against